49 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
), or overnight air courier with proof of delivery (i) if to the Company, at its principal corporate offices addressed to the attention of the Chief Human
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
27 Jul 23
Departure of Directors or Certain Officers
4:48pm
air courier with proof of delivery (i) if to the Company, at its principal corporate offices addressed to the a en on of the Chief Human Resources
8-K
EX-10.2
EBS
Emergent Biosolutions Inc
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
into the environment, including those related to hazardous substances or wastes, air emissions and discharges to waste or public systems
8-K
EX-2
7g7a4l
18 May 22
Entry into a Material Definitive Agreement
5:13pm
8-K/A
EX-10.1
42aam ff6p70kn
9 Sep 21
Financial Statements and Exhibits
4:33pm
8-K
EX-10.1
mg44puzq1z sh8
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:33pm
8-K
EX-4.1
1lo6ybof9o
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:33pm
8-K
EX-4.1
kxdy86xx4nq5
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-10.1
cto1x
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-10
f2ufgvju13a5u7
15 Oct 18
Completion of Acquisition or Disposition of Assets
5:22pm
8-K
EX-2.1
4bsm1t80lj re
5 Oct 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-2
60b 7j0h2hg3ck
14 Jul 17
Emergent Biosolutions to Acquire ACAM2000® Business from Sanofi
12:00am
8-K
EX-10
u68c0w0ubj1i
29 Jan 14
Emergent Biosolutions Announces Completion of $250 Million Convertible Senior Notes Offering
12:00am